rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jonathan Rigby

Director

Company insider

Files Form 4 as: Director, Oncolytics Biotech; Director, Xeris Pharmaceuticals; President and CEO, SteadyMed; VP, Business Development, Aradigm.

In numbers

Trades disclosed
25
Buys
0
Sells
5
Bought
$0
Sold
$1.1M
Companies
4
Companies where not an officer
2
First trade
12 Apr 2006
Last trade
1 Jun 2026
Last filed
3 Jun 2026

Companies traded

Where they are an officer
SteadyMedDirector, Officer · last 30 Aug 20180 buys · 5 sells
AradigmOfficer · last 12 Apr 20060 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ONCY Oncolytics BiotechDirector · Biotechnology · last 1 Jun 20260 buys · 0 sells
Xeris PharmaceuticalsDirector · last 27 Feb 20190 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Jun 2026filed 3 Jun 2026ONCY Oncolytics Biotechoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
1 Jun 2026filed 3 Jun 2026ONCY Oncolytics Biotechoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
27 Feb 2019filed 1 Mar 2019Xeris Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—20,000 at $0.00filing
30 Aug 2018filed 4 Sep 2018SteadyMedSEC FORM 4 Sold$186K41,605 at $4.46filing
30 Aug 2018filed 4 Sep 2018SteadyMedSEC FORM 4 Sold$22K4,960 at $4.46filing
30 Aug 2018filed 4 Sep 2018SteadyMedoption or derivativeSEC FORM 4 Code J—18,515 at $0.00filing
30 Aug 2018filed 4 Sep 2018SteadyMedoption or derivativeSEC FORM 4 Code J—145,212 at $0.00filing
30 Aug 2018filed 4 Sep 2018SteadyMedoption or derivativeSEC FORM 4 Code J—131,451 at $0.00filing
30 Aug 2018filed 4 Sep 2018SteadyMedoption or derivativeSEC FORM 4 Code J—63,764 at $0.00filing
30 Aug 2018filed 4 Sep 2018SteadyMedoption or derivativeSEC FORM 4 Code J—163,394 at $0.00filing
24 Aug 2018filed 27 Aug 2018SteadyMedoption or derivativeSEC FORM 4 Code M—16,994 at $0.00filing
24 Aug 2018filed 27 Aug 2018SteadyMedSEC FORM 4 Code M$47K16,994 at $2.74filing
24 Aug 2018filed 27 Aug 2018SteadyMedSEC FORM 4 Sold$80K16,994 at $4.70filing
23 Aug 2018filed 27 Aug 2018SteadyMedoption or derivativeSEC FORM 4 Code M—44,242 at $0.00filing
23 Aug 2018filed 27 Aug 2018SteadyMedSEC FORM 4 Code M$121K44,242 at $2.74filing
23 Aug 2018filed 27 Aug 2018SteadyMedSEC FORM 4 Sold$209K44,242 at $4.73filing
17 Aug 2018filed 17 Aug 2018SteadyMedSEC FORM 4 Sold$414K88,831 at $4.66filing
9 Aug 2018filed 10 Aug 2018SteadyMedSEC FORM 4 Code M$321K88,831 at $3.61filing
9 Aug 2018filed 10 Aug 2018SteadyMedoption or derivativeSEC FORM 4 Code M—88,831 at $0.00filing
2 Jul 2018filed 3 Jul 2018SteadyMedSEC FORM 4 Sold$187K41,605 at $4.50filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed5

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.